December 10, 2024 - 06:27

Donald Trump faced significant backlash on Monday regarding his nomination for Secretary of Health and Human Services. A group of over 60 Nobel Prize laureates issued a public letter expressing their strong opposition to Robert F. Kennedy Jr.'s appointment. The esteemed scientists and scholars emphasized their concerns about Kennedy's controversial views on vaccines and public health, arguing that his leadership could undermine critical health initiatives in the United States.
The letter highlighted the importance of evidence-based science in health policy, urging the Senate to consider the potential ramifications of appointing someone who has consistently promoted misinformation. The laureates stressed that public trust in health institutions is paramount, especially in light of recent global health crises. They called on lawmakers to prioritize the well-being of Americans and to select a candidate who embodies a commitment to scientific integrity and public health.
As the Senate prepares to review the nomination, the growing chorus of dissent from the scientific community raises questions about the future of health policy under a Trump administration.
March 31, 2026 - 08:40
SF Supervisor Jackie Fielder on leave due to mental health condition; her staff set to take overSan Francisco Supervisor Jackie Fielder is taking a temporary leave of absence from her official duties to address a mental health condition, her office confirmed this week. The announcement...
March 30, 2026 - 19:56
CVS Health puts creative and media in reviewCVS Health has launched a comprehensive review of its creative and media agency partnerships, a significant move that puts its substantial advertising account under scrutiny. This decision comes as...
March 30, 2026 - 15:51
New £1.5m research facility plan for New Cross HospitalA major £1.5 million investment is set to establish a new clinical research facility at New Cross Hospital, a move heralded by NHS leaders as a significant advancement for patient care, medical...
March 29, 2026 - 18:52
Makers of dietary supplements push the FDA to allow peptides and other new ingredientsThe dietary supplement industry is actively urging the U.S. Food and Drug Administration to modernize its regulatory approach to allow novel ingredients, including peptides and other compounds,...